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group C, n  23 (Excluder, W.L.Gore) and group D,
n10 Endurant (Medtronic, Inc.).
Results: Epidemiological characteristics, atheroscle-
rotic risk factors, type of anesthesia, mean blood loss during
surgery and baseline serum levels of cytokines did not differ
among the patients of the four groups. Mean temperature
was more pronounced postoperatively in group A. Serum
levels of IL-6, and IL-10 were significantly higher 24 and
48 hours postoperatively compared to preoperative levels in
all groups. Patients in Group C presented the smallest
increase in levels of serum IL-6, and IL-10, 24 and 48
hours postoperatively. Mean difference in cytokines levels
after aneurysm exclusion was higher for group A versus C
(P .01) compared to group A versus B (P .05). In-
creased inflammatory response was associated with pro-
longed hospital stay.
Conclusions: Endograft type appears to influence the
inflammatory response following EVAR. The impact of
postimplantation inflammatory response in clinical out-
comes requires further investigation.
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Objectives: Cerebral embolism is a feared complica-
tion of carotid artery stenting (CAS) and might be associ-
ated with specific morphological patterns, however sero-
logical predictors of risk have been scarcely investigated.
Methods: Consecutive patients with carotid artery ste-
nosis undergoing filter-protected CAS were preoperatively
evaluated to identify unstable plaque at duplex ultrasound,
complicated aortic plaque at trans-esophageal echocardiog-
raphy and inflammatory status with high sensitivity C-reac-
tive proteins (hs-CRP) and serum amyloid-A protein (SSA)
serum levels. Aortic arch type, carotid tortuosity, and com-
plexity of the procedure were considered. Cerebral embo-
lism was evaluated by comparing number, volume and side
of preoperative and postoperative cerebral lesions at diffu-
sion weight resonance magnetic imaging (DW-RMI) and
through light and scanning electron microscopy analysis of
cerebral protection filters obtained from CAS.
Results: Twenty consecutive patients were submitted
to CAS with no complications. At least 1 asymptomatic
cerebral lesion on DW-MRI was present in 18 (90%) pa-
tients. Female gender was associated with a higher number
of cerebral lesions (18.210.9 vs. 8.38.8 P  .03).
Plaque morphology, supraaortic vessels anatomy and pro-
cedure complexity did not correlate with number or vol-
ume of new cerebral lesions at DW-RMI. The presence of
complicated aortic plaque was associated with higher vol-
ume of contralateral cerebral lesions (23502593 vs.
636632 mm3 P .02). Hs-CRP5mg/l and SAA10
mg/l were significantly associated with a higher number of
cerebral lesions (16.2  10.7 vs. 4.33.4 P  .02, and
14.8  10.3 vs. 2.8  3.4 P  .006, respectively). Hs-
CRP5 and SAA10 mg/l also correlated with greater
surface involvement by embolic materials in the protection
filters at microscopic analysis (37.0  5.7 vs. 26.9  2.5
P  .004).
Conclusions: Inflammatory status is associated with
higher embolic risk during CAS independent from mor-
phological and technical aspects of the procedure.
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Objectives: Carotid Magnetic Resonance Imaging
(MRI) may be a usefull tool to characterize carotid plaque
vulnerability, but large studies are still lacking. The purpose
of this study is to assess carotid MRI features of vulnerable
plaque in a large study and assess changes in carotid plaque
morphology with time since neurologic event.
Methods: We included 161 patients with carotid
plaque. All underwent a carotid MRI using 3T High Res-
olution MR sequences. Stenosis degree, plaque thickness,
plaque type (lipidic, fibrotic, calcified), Intra-plaque hem-
orrhage (IPH), fibrous cap rutpure (FCR) and gadolinium
enhancement (GE) were assessed. Plaque type was classi-
fied on the basis of the predominant component of the
plaque. IPH, FCR and GE were classified as absent or
present.
Results: 7 patients were excluded because of poor
image quality. In the 154 remaining patients, 52 were
symptomatic (41 strokes, 7 transient ischemic attacks and 4
amaurosis in the last 6 month) and 102 asymptomatic. IPH
(39 vs 16%; P .002), FCR (30 vs 9%; P.0001), GE (77
vs 55%; P .014) were significantly higher in symptomatic
versus asymptomatic plaque. No difference were observed
for stenosis degree or plaque thickness. Plaques with exten-
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sive calcification were observed more frequently in asymp-
tomatic patients (43 vs 22%; P .014). IPH is significantly
higher in symptomatic plaque regardless of the time since
the neurologic event. For FCR difference between symp-
tomatic and asymtptomatic are significant only during the
first 15 days following the neurological event.
Conclusions: Carotid MRI can identify plaque fea-
tures that are associated with symptomatic presentation and
may be indicative of plaque vulnerability. These features
may ultimately be utilized in the management of extracra-
nial carotid stenosis.
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Objectives: Patients presenting with carotid-related
acute neurological symptoms are at hightened risk of
stroke. Urgent CEA (uCEA) during the index hospitaliza-
tion is indicated in select patients. We aimed to determine
the effect of a dedicated vascular neurology team on the
volume of uCEAs and assess outcomes.
Methods: CEAs (n436) performed at a tertiary cen-
ter between 2005-2011 were analyzed. Chi-square was
used to compare the uCEA volume pre- (June 2005-Aug.
2008) and post- (Sept. 2008-Nov. 2011) implementation
of a vascular neurology service. Fisher’s exact and t-tests
were used to analyze perioperative outcomes.
Results: The proportion of uCEAs performed in-
creased significantly after initiation of a vascular neurology
service (4.1% [7/172] vs. 22.2% [49/221], P  .0001).
Per annum, uCEAs increased from 5.3% (4/75) in 2005 to
39.6% (25/63) in 2011 (Fig). uCEA indications were
stroke-in-evolution 10% (5/49), crescendo TIAs 6% (3/
49), acute stroke 45% (22/49), and cerebral/ocular TIAs
39% (19/49). Mean National Institutes of Health Stroke
Scale (NIHSS) was 3.5 (0-24); mean TIA score was 5
(1-8). A trend towards a higher combined stroke/death
rate in the urgent compared to the elective symptomatic
CEA group group was present (7.1 % [3/49] vs. 2% [1/
49]; p .36); however, patients undergoing uCEAwith an
NIHSS10 had no perioperative complications.
Conclusions: Collaboration with a vascular neurology
team increased the volume of uCEAs over a three year
period. In patients with mild strokes (NIHSS10), uCEA
outcomes approximate those for electively-performed
CEAs.
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Objectives: SCI is a devastating complication of TE-
VAR with varying degrees of disability. Here we review the
outcomes of patients with SCI after TEVAR.
Methods: Patients with SCI after TEVAR, defined
by any lower extremity neuro deficit over baseline, were
evaluated. A database query and chart review/phone
interviews with patients/family were used to determine
outcomes and functional status after discharge. Patients
were analyzed based on functional recovery and timing
of their CSF drain placement(prophylactic or post-op for
symptoms).
Results: 609 TEVARs were performed in the study
period, and 57 patients developed SCI (9.4%). In-hospital
mortality with SCI was 7.0%. 54 patients (95%) had a CSF
drain placed with the majority placed post-op (54%). Com-
plete data were available for 34 patients (60%) of whom 27
(47%) were alive at follow-up[median 11.8mos]. Of these
34 patients, 26 (76%) had functional improvement, with 12
(35%) reporting return to baseline. Survival was worse in
patients with no functional improvement (NI) when com-
pared to patients with improvement (WI). Median survival
for WI patients was 56mos compared to 3mos (P.001) in
NI patients. No difference in functional improvement or
Fig. *September 2008: Vascular neurology service implementa-
tion
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